“…Uncontrolled hemorrhage caused by severe injuries during surgery procedures and emergencies often leads to a high risk of morbidity, accounting for more than 30% of global trauma-related deaths each year. − Utilizing topical hemostatic agents for quick and effective bleeding control is crucial in improving survival and subsequent wound recovery. − Over the past decades, tremendous research efforts have been made and hemostatic agents come in many flavors, such as gauze/bandage, , granule/powder, − sponge/foam, , hydrogel, − paste, and cryogel, , etc. Among these materials, hydrogel-based bioadhesives that block the bleeding sites through adhesive sealing have risen as promising alternatives or adjuncts to the invasive suturing and stapling techniques for trauma management, owing to their easy-to-use, hydrated three-dimensional (3D) networks and structurally similar to extracellular matrix (ECM), tunable physicochemical properties, and permeability to oxygen and nutrient for wound healing. , In particular, the in situ forming injectable hydrogel adhesives are highly beneficial for conforming and filling the deep, narrow, and irregularly shaped defects in a minimally invasive fashion. − However, the clinically available injectable adhesives (such as fibrin glue, cyanoacrylate, and albumin-glutaraldehyde BioGlues) generally display several limitations, including slow adhesion formation, weak wet adhesion strength, unsatisfied mechanical performance, and even poor biocompatibility and biodegradability, which may result in a substantially compromised hemostatic outcome and delayed wound healing. , Given the magnitude of these problems, developing an injectable hydrogel capable of integrating high mechanical strength, fast tough tissue adhesion, and facilitating tissue repair is highly desirable clinically and remains an ongoing challenge.…”